MySize Raises $2.5 Million in Private Placement

The offering includes unregistered Series C and Series D warrants, each allowing the purchase of up to 1,308,901 shares of common stock. Both series carry an exercise price of $1.66 per share and are immediately exercisable. While the Series C warrants feature a five-year term, the Series D instruments expire 18 months after the effective date of the required resale registration statement.

H.C. Wainwright & Co. is serving as the exclusive placement agent for the deal. MySize leadership plans to allocate the net proceeds toward general corporate purposes, including working capital. The company, which is currently diversifying its portfolio to include defense technology, remains subject to customary closing conditions before the transaction concludes.